Very few studies in literature report association of congenital heart defect with azathioprine
Besides anti-TNF agent-related cases, one UC case complicated with LM has been reported in the literature; the case was related to azathioprine
In the studies that evaluated the risk of squamous cell carcinoma, risk was elevated by 56% among patients treated with azathioprine
(95% confidence interval, 1.
and 6-mercaptopurine can also cause side effects, including allergic reactions, leucopenia, pancreatitis, nausea, and abnormal liver function tests.
7 years and the mean follow-up time from the start of the treatment with azathioprine
Toxicity of methotrexate compared with azathioprine
in the treatment of rheumatoid arthritis: a case-control study of 131 patients.
and 6-mercatopurine (6-MP) are effective treatments for inflammatory bowel disease.
pulse therapy, APT, psoriasis, methotrexate.
The short duration of diabetes research opportunities for Oxidative damage in mice did not develop type II diabetes, especially the long-term effect, On the other hand, according to some studies, after taking some poison , or drugs such as azathioprine
, MDA in blood or tissue, is increased .
is still widely used for moderate to severe lupus in 2012.
The study, known as PANTHER-IPF (Prednisone, Azathioprine
, and N-acetylcysteine; A Study That Evaluates Response in Idiopathic Pulmonary Fibrosis), was designed to evaluate the effectiveness of a triple-therapy regimen in slowing disease progression and improving lung function in patients with moderate to severe IPF.
An increasing number of women of reproductive age are being treated with azathioprine
(Imuran) for inflammatory bowel disease (IBD) because the peak incidence of the disease is among women in this age group.
After methotrexate (whose use is widespread in psoriasis), azathioprine
is the immunosuppressant most widely used by dermatologists because of its immunosuppressive effect, which is superior to methotrexate, has less serious side effects than cyclosporine, and a lower cost than that of mycophenolate, tracolimus and sirolimus.
After being treated for up to three years, participants in the trial taking CellCept[R] were able to stave off "treatment failure" for a significantly longer time than those on the "standard of care" drug, azathioprine
The team studied the incidence of cancer among 481 kidney transplant recipients who each received one of three treatment regimens: azathioprine
and prednisone, cyclosporine monotherapy, or cyclosporine monotherapy followed by a switch to azathioprine
and prednisone after three months.